Actavis | search
Click here to view Actavis news from 60+ newspapers.
Bookmark or Share- Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion ...Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction - Creates an Innovative New Model in Specialty Pharmaceuticals Leadership, with $15 Billion...
- Actavis - WikipediaActavis Generics (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial ...
- Teva Receives Clearance from the U.S. Federal Trade ...Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) (TASE:TEVA) and Allergan plc (NYSE:AGN) today announced that the U.S. Federal Trade Commission (FTC) has accepted the proposed consent order in connection with the pending acquisition of Allergan’s generics business (“Actavis Generics”) by Teva Pharmaceutical Industries Ltd.
- Teva Announces Sale of UK and Ireland Actavis Assets and ...Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it has agreed to sell assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd) for an agreed value of GBP 603 million, subject to final approval from the European Commission.
- Teva Completes Acquisition of Actavis GenericsTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) today announced that Teva has completed its acquisition of Allergan’s generics business (“Actavis Generics”). This strategic acquisition brings together two leading generics businesses with complementary strengths, R&D capabilities, product pipelines ...
More
